CSL News: Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³ - 13th Feb 2024, 2:54pm

You must log in or register to reply here.

Similar threads

annb0t
CSL News: Half year reported NPATA US$2 billion¹,² Up 13% at constant currency³ - 13th Feb 2024, 5:21pm
Replies
0
Views
60
annb0t
annb0t
annb0t
CSL News: ARS Pharmaceuticals Submits Response for neffy® (epinephrine nasal spray) Marketing Authorization - 30th Apr 2024, 11:01pm
Replies
0
Views
47
annb0t
annb0t
annb0t
CSL News: Travere Therapeutics and CSL Vifor Announce European Commission Approves FILSPARI® (sparsentan) f - 24th Apr 2024, 9:05pm
Replies
0
Views
48
annb0t
annb0t
annb0t
CSL News: CSL Vifor and Travere Therapeutics Announce European Commission approves FILSPARI® (sparsentan) f - 24th Apr 2024, 5:00pm
Replies
0
Views
28
annb0t
annb0t
annb0t
CSL News: CSL Limited (ASX:CSL) On An Uptrend: Could Fundamentals Be Driving The Stock? - 3rd Apr 2024, 9:13am
Replies
0
Views
73
annb0t
annb0t
Top Bottom